Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective..Teijeira L, Martínez M, Moreno A, de Elejoste I, Ibáñez-Beroiz B, Arrazubi V, Díaz de Corcuera I, Elejalde I, Campillo-Calatayud A, Les I.
Cancers, 16, .
2023 Pharmacological interactions and menopausal hormone therapy: a review..Fasero M, Quereda F, Andraca L, Coronado PJ, HT Eligibility Criteria Group.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 30, 873-880.
2023 Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.Les, I, Martínez, M, Pérez-Francisco, I, Cabero, M, Teijeira, L, Arrazubi, V, Torrego, N, Campillo-Calatayud, A, Elejalde, I, Kochan, G, Escors, D.
Cancers, 15, .
2023 Impact of the "Looking after my health after cancer" peer-led active patient education program on cancer survivors and their caregivers: A qualitative study.Ulibarri-Ochoa, Ainhoa, Sanchez-Gomez, Sheila, Gamboa-Moreno, Estibaliz, Duo-Trecet, Irene, Garate-Echenique, Lucia, Belarra-Tellechea, Begona, Retana-Garcia, Lourdes Ochoa de.
PLOS ONE, 18, 282018-282018.
2023 Image processing tools for the validation of CryoEM maps (vol 240, pg 210, 2022).Sorzano, C. O. S., Vilas, J. L., Ramirez-Aportela, E., Krieger, J., del Hoyo, D., Herreros, D., Fernandez-Gimenez, E., Marchan, D., Gomez, F. de Isidro, Macias, J. R., Sanchez, I, del Cano, L., Fonseca-Reyna, Y., Conesa, P., Garcia-Mena, A., Burguet, J., Condado, J. Garcia, Garcia, J. Mendez, Martinez, M., Munoz-Barrutia, A., Marabini, R., Vargas, J., Carazo, J. M..
Faraday Discussions, 240, 228-228.
2022 Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.Les, I., Pérez-Francisco, I., Cabero, M., Sánchez, C., Hidalgo, M., Teijeira, L., Arrazubi, V., Domínguez, S., Anaut, P., Eguiluz, S., Elejalde, I., Herrera, A., Martínez, M..
FRONTIERS IN PHARMACOLOGY, 13, .
2022 ESTRATEGIAS DE AFRONTAMIENTO PARA EL DESARROLLO DE LA RESILIENCIA EN PADRES DE NIÑOS CON CÁNCER.ÁLVAREZ FLORES, IRENE, ULIBARRI OCHOA, AINHOA.
REVISTA OFICIAL DE LA SOCIEDAD ESPAÑOLA DE ENFERMERÍA ONCOL, 24, .
2022 Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies..Les I, Martínez M, Narro A, Pérez I, Sánchez C, Puntí L, Anaut P, Eguiluz S, Herrera A, Domínguez S.
ANNALS OF MEDICINE, 53, 762-769.
2021 The impact of COVID-19 pandemic on Spanish genitourinary (GU) cancer patients: SOGUG-COVID-19 study.Duran, MAC, Vidal, N, Perez, S, Mendez-Vidal, MJ, Anguera, G, Salas, IM, Gallardo, E, Cuellar, MA, Soto, JJ, Martin, A, Domenech, M, Rodriguez-Vida, A, Casado, EA, Diaz-Mejia, N, Kareaga, MM, Calvo, OF, Guzman, JCV, Vazquez, S, del Alba, AG, Puente, J.
ANNALS OF ONCOLOGY, 32, 1136-1137.
2021 Lung cancer patients with COVID-19 in Spain: GRAVID study..Provencio M, Mazarico Gallego JM, Calles A, Antoñanzas M, Pangua C, Mielgo Rubio X, Nadal E, Castro RL, López-Martín A, Del Barco E, Dómine M, Franco F, Diz P, Sandoval C, Girona ES, Sullivan I, Sala MÁ, Ledo GG, Cucurull M, Mosquera J, Martínez M, Chara LE, Arriola E, Herrera BE, Jarabo JR, Álvarez RÁ, Baena J, Cao MG.
LUNG CANCER, 157, 109-115.
2021 
